Clinical-Grade Wearable Remote Patient Monitoring Market Global Report 2026

The clinical-grade wearable remote patient monitoring market size has grown exponentially in recent years. It will grow from $123.21 billion in 2025 to $149.24 billion in 2026 at a compound annual growth rate (CAGR) of 21.1%. The growth during the historic period was driven by increasing prevalence of chronic diseases, rising adoption of remote healthcare services, growing demand for continuous health monitoring, expansion of telemedicine infrastructure, and increasing healthcare focus on preventive care.

The clinical-grade wearable remote patient monitoring market size is expected to see exponential growth in the next few years. It will grow to $323.75 billion in 2030 at a compound annual growth rate (CAGR) of 21.4%. The growth during the forecast period can be attributed to growing demand for personalized healthcare monitoring, increasing adoption of home-based patient care solutions, rising investments in wearable medical technology, expanding use of real-time health analytics, and increasing need for cost-efficient healthcare delivery models. Major trends during the forecast period include increasing adoption of regulatory-compliant wearable health monitoring devices, growing demand for real-time patient health data transmission, rising integration of advanced biosensors in medical wearable devices, expansion of remote patient monitoring programs across healthcare systems, and increasing development of compact multi-parameter wearable monitoring solutions.

The growing adoption of telehealth is expected to drive the growth of the clinical-grade wearable remote patient monitoring market in the coming years. Telehealth refers to the provision of healthcare services and clinical information through digital communication technologies, including video consultations, mobile applications, and remote monitoring systems, allowing patients to access healthcare without requiring physical visits. The increasing adoption of telehealth is driven by the rising demand for convenient and accessible healthcare solutions, as virtual care allows patients to receive medical assistance remotely without frequent hospital appointments. Clinical-grade wearable remote patient monitoring supports telehealth by facilitating continuous and real-time collection of physiological data outside traditional healthcare environments, improving remote diagnosis, personalized treatment planning, and proactive patient care management. For example, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, national telehealth utilization increased by 7.3% in 2023, growing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, growing telehealth adoption is driving the growth of the clinical-grade wearable remote patient monitoring market.

Major companies operating in the clinical-grade wearable remote patient monitoring market are concentrating on developing advanced platforms, such as multi-sensor remote patient monitoring (RPM) platforms, to enhance real-time patient monitoring, enable decentralized healthcare delivery, and improve clinical decision-making. A multi-sensor remote patient monitoring (RPM) platform is a digital healthcare solution that combines information from multiple wearable devices or connected sensors to continuously monitor a patient’s vital signs and health parameters in real time outside healthcare facilities for remote evaluation and care management. For instance, in January 2024, Blue Spark Technologies Inc., a US-based digital health technology company, launched VitalTraq, an advanced multi-vital remote patient monitoring platform designed to enhance continuous patient monitoring and support decentralized clinical trials. The platform combines AI-powered contactless remote photoplethysmography (rPPG) facial scanning technology with the company’s TempTraq wearable temperature monitoring patch to monitor vital signs, including heart rate, blood pressure, respiratory rate, heart rate variability, and continuous body temperature, through a single mobile application. The HIPAA-compliant solution also provides cloud-based connectivity and a web-based monitoring dashboard, allowing healthcare providers and researchers to efficiently access real-time patient health information while minimizing dependence on multiple monitoring devices.

In March 2026, Vitalist Inc., a US-based wearable technology and software company, acquired Somatix for an undisclosed amount. Through this acquisition, Vitalist Inc. aims to enhance its medical-grade AI capabilities and expand its global remote patient monitoring ecosystem by incorporating Somatix’s behavioral sensing and wearable intelligence technologies into its existing VitalOS platform to improve real-time clinical insights and patient engagement. Somatix Inc. is a US-based company that offers clinical-grade wearable remote patient monitoring (RPM) solutions.

Major companies operating in the clinical-grade wearable remote patient monitoring market are Abbott, Adherium Limited, Aktiia SA, Biobeat Technologies Ltd., BioIntelliSense Inc., Cloud DX Inc., Dexcom, Empatica Inc., iRhythm, InfoBionic Inc., Isansys Lifecare Ltd., Lief Therapeutics Inc., Masimo, MediBioSense Ltd., Medtronic, Nanowear Inc., Shimmer Research Ltd., SmartCardia SA, Tenovi Inc., TytoCare Ltd., VitalConnect Inc., VivaLNK Inc.

North America was the dominating region in the clinical-grade wearable remote patient monitoring market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the clinical-grade wearable remote patient monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical-grade wearable remote patient monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.